CompletedPHASE2, PHASE3NCT00485511

A Trial of Hydroxyurea in Spinal Muscular Atrophy

Studying Autosomal dominant adult-onset proximal spinal muscular atrophy

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Kaohsiung Medical University Chung-Ho Memorial Hospital
Principal Investigator
Yuh Jyh Jong, MD
Vice President, Kaohsiung Medical University
Intervention
Hydroxyurea(drug)
Eligibility
4 years · All sexes
Timeline
20072009

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00485511 on ClinicalTrials.gov

Other trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

Additional recruiting or active studies for the same condition.

See all trials for Autosomal dominant adult-onset proximal spinal muscular atrophy

← Back to all trials